Global Contrast Agent Market Research Report 2023(Status and Outlook)
Report Overview
A contrast agent is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast agents, enhance the radiodensity in a target tissue or structure.
The Global Contrast Agent Market Size was estimated at USD 5313.5 million in 2022 and is projected to reach USD 7279.52 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Contrast Agent market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Contrast Agent Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Contrast Agent market in any manner.
Global Contrast Agent Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer Healthcare Pharmaceuticals
Medrad
Lantheus Medical
ACIST Medical Systems
AMAG Pharmaceuticals
Pinyons Medical Technology
Targeson
Beekley Medical
Mallinckrodt Pharmaceuticals
Nova Biomedical
NycomedAmersham
Daiichi
Medtronic
GE Healthcare
Bracco Diagnostic
Guerbet
Market Segmentation (by Type)
Gadolinium-Based Contrast Media
Barium-Based Contrast Media
Iodinated Contrast Media
Market Segmentation (by Application)
At Home
Away From Home
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Contrast Agent Market
Overview of the regional outlook of the Contrast Agent Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Contrast Agent
- 1.2 Key Market Segments
- 1.2.1 Contrast Agent Segment by Type
- 1.2.2 Contrast Agent Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Contrast Agent Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Contrast Agent Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Contrast Agent Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Contrast Agent Market Competitive Landscape
- 3.1 Global Contrast Agent Sales by Manufacturers (2018-2023)
- 3.2 Global Contrast Agent Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Contrast Agent Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Contrast Agent Sales Sites, Area Served, Product Type
- 3.6 Contrast Agent Market Competitive Situation and Trends
- 3.6.1 Contrast Agent Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Contrast Agent Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Contrast Agent Industry Chain Analysis
- 4.1 Contrast Agent Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Contrast Agent Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Contrast Agent Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Contrast Agent Sales Market Share by Type (2018-2023)
- 6.3 Global Contrast Agent Market Size Market Share by Type (2018-2023)
- 6.4 Global Contrast Agent Price by Type (2018-2023)
- 7 Contrast Agent Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Contrast Agent Market Sales by Application (2018-2023)
- 7.3 Global Contrast Agent Market Size (M USD) by Application (2018-2023)
- 7.4 Global Contrast Agent Sales Growth Rate by Application (2018-2023)
- 8 Contrast Agent Market Segmentation by Region
- 8.1 Global Contrast Agent Sales by Region
- 8.1.1 Global Contrast Agent Sales by Region
- 8.1.2 Global Contrast Agent Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Contrast Agent Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Contrast Agent Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Contrast Agent Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Contrast Agent Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Contrast Agent Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Bayer Healthcare Pharmaceuticals
- 9.1.1 Bayer Healthcare Pharmaceuticals Contrast Agent Basic Information
- 9.1.2 Bayer Healthcare Pharmaceuticals Contrast Agent Product Overview
- 9.1.3 Bayer Healthcare Pharmaceuticals Contrast Agent Product Market Performance
- 9.1.4 Bayer Healthcare Pharmaceuticals Business Overview
- 9.1.5 Bayer Healthcare Pharmaceuticals Contrast Agent SWOT Analysis
- 9.1.6 Bayer Healthcare Pharmaceuticals Recent Developments
- 9.2 Medrad
- 9.2.1 Medrad Contrast Agent Basic Information
- 9.2.2 Medrad Contrast Agent Product Overview
- 9.2.3 Medrad Contrast Agent Product Market Performance
- 9.2.4 Medrad Business Overview
- 9.2.5 Medrad Contrast Agent SWOT Analysis
- 9.2.6 Medrad Recent Developments
- 9.3 Lantheus Medical
- 9.3.1 Lantheus Medical Contrast Agent Basic Information
- 9.3.2 Lantheus Medical Contrast Agent Product Overview
- 9.3.3 Lantheus Medical Contrast Agent Product Market Performance
- 9.3.4 Lantheus Medical Business Overview
- 9.3.5 Lantheus Medical Contrast Agent SWOT Analysis
- 9.3.6 Lantheus Medical Recent Developments
- 9.4 ACIST Medical Systems
- 9.4.1 ACIST Medical Systems Contrast Agent Basic Information
- 9.4.2 ACIST Medical Systems Contrast Agent Product Overview
- 9.4.3 ACIST Medical Systems Contrast Agent Product Market Performance
- 9.4.4 ACIST Medical Systems Business Overview
- 9.4.5 ACIST Medical Systems Contrast Agent SWOT Analysis
- 9.4.6 ACIST Medical Systems Recent Developments
- 9.5 AMAG Pharmaceuticals
- 9.5.1 AMAG Pharmaceuticals Contrast Agent Basic Information
- 9.5.2 AMAG Pharmaceuticals Contrast Agent Product Overview
- 9.5.3 AMAG Pharmaceuticals Contrast Agent Product Market Performance
- 9.5.4 AMAG Pharmaceuticals Business Overview
- 9.5.5 AMAG Pharmaceuticals Contrast Agent SWOT Analysis
- 9.5.6 AMAG Pharmaceuticals Recent Developments
- 9.6 Pinyons Medical Technology
- 9.6.1 Pinyons Medical Technology Contrast Agent Basic Information
- 9.6.2 Pinyons Medical Technology Contrast Agent Product Overview
- 9.6.3 Pinyons Medical Technology Contrast Agent Product Market Performance
- 9.6.4 Pinyons Medical Technology Business Overview
- 9.6.5 Pinyons Medical Technology Recent Developments
- 9.7 Targeson
- 9.7.1 Targeson Contrast Agent Basic Information
- 9.7.2 Targeson Contrast Agent Product Overview
- 9.7.3 Targeson Contrast Agent Product Market Performance
- 9.7.4 Targeson Business Overview
- 9.7.5 Targeson Recent Developments
- 9.8 Beekley Medical
- 9.8.1 Beekley Medical Contrast Agent Basic Information
- 9.8.2 Beekley Medical Contrast Agent Product Overview
- 9.8.3 Beekley Medical Contrast Agent Product Market Performance
- 9.8.4 Beekley Medical Business Overview
- 9.8.5 Beekley Medical Recent Developments
- 9.9 Mallinckrodt Pharmaceuticals
- 9.9.1 Mallinckrodt Pharmaceuticals Contrast Agent Basic Information
- 9.9.2 Mallinckrodt Pharmaceuticals Contrast Agent Product Overview
- 9.9.3 Mallinckrodt Pharmaceuticals Contrast Agent Product Market Performance
- 9.9.4 Mallinckrodt Pharmaceuticals Business Overview
- 9.9.5 Mallinckrodt Pharmaceuticals Recent Developments
- 9.10 Nova Biomedical
- 9.10.1 Nova Biomedical Contrast Agent Basic Information
- 9.10.2 Nova Biomedical Contrast Agent Product Overview
- 9.10.3 Nova Biomedical Contrast Agent Product Market Performance
- 9.10.4 Nova Biomedical Business Overview
- 9.10.5 Nova Biomedical Recent Developments
- 9.11 NycomedAmersham
- 9.11.1 NycomedAmersham Contrast Agent Basic Information
- 9.11.2 NycomedAmersham Contrast Agent Product Overview
- 9.11.3 NycomedAmersham Contrast Agent Product Market Performance
- 9.11.4 NycomedAmersham Business Overview
- 9.11.5 NycomedAmersham Recent Developments
- 9.12 Daiichi
- 9.12.1 Daiichi Contrast Agent Basic Information
- 9.12.2 Daiichi Contrast Agent Product Overview
- 9.12.3 Daiichi Contrast Agent Product Market Performance
- 9.12.4 Daiichi Business Overview
- 9.12.5 Daiichi Recent Developments
- 9.13 Medtronic
- 9.13.1 Medtronic Contrast Agent Basic Information
- 9.13.2 Medtronic Contrast Agent Product Overview
- 9.13.3 Medtronic Contrast Agent Product Market Performance
- 9.13.4 Medtronic Business Overview
- 9.13.5 Medtronic Recent Developments
- 9.14 GE Healthcare
- 9.14.1 GE Healthcare Contrast Agent Basic Information
- 9.14.2 GE Healthcare Contrast Agent Product Overview
- 9.14.3 GE Healthcare Contrast Agent Product Market Performance
- 9.14.4 GE Healthcare Business Overview
- 9.14.5 GE Healthcare Recent Developments
- 9.15 Bracco Diagnostic
- 9.15.1 Bracco Diagnostic Contrast Agent Basic Information
- 9.15.2 Bracco Diagnostic Contrast Agent Product Overview
- 9.15.3 Bracco Diagnostic Contrast Agent Product Market Performance
- 9.15.4 Bracco Diagnostic Business Overview
- 9.15.5 Bracco Diagnostic Recent Developments
- 9.16 Guerbet
- 9.16.1 Guerbet Contrast Agent Basic Information
- 9.16.2 Guerbet Contrast Agent Product Overview
- 9.16.3 Guerbet Contrast Agent Product Market Performance
- 9.16.4 Guerbet Business Overview
- 9.16.5 Guerbet Recent Developments
- 10 Contrast Agent Market Forecast by Region
- 10.1 Global Contrast Agent Market Size Forecast
- 10.2 Global Contrast Agent Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Contrast Agent Market Size Forecast by Country
- 10.2.3 Asia Pacific Contrast Agent Market Size Forecast by Region
- 10.2.4 South America Contrast Agent Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Contrast Agent by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Contrast Agent Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Contrast Agent by Type (2024-2029)
- 11.1.2 Global Contrast Agent Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Contrast Agent by Type (2024-2029)
- 11.2 Global Contrast Agent Market Forecast by Application (2024-2029)
- 11.2.1 Global Contrast Agent Sales (K MT) Forecast by Application
- 11.2.2 Global Contrast Agent Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook